Results for tag: "Osteogenesis Imperfecta Drug"

Osteogenesis Imperfecta (OI) is a rare genetic disorder that affects the bones and connective tissues. It is caused by a mutation in the gene that produces collagen, a protein that gives bones their strength. Endocrine and Metabolic Disorders Drugs are used to treat OI, as they can help to reduce the risk of fractures and improve bone strength. These drugs can also help to reduce pain and improve mobility. Commonly used drugs include bisphosphonates, calcitonin, and teriparatide. Bisphosphonates are used to reduce bone resorption and increase bone density, while calcitonin helps to reduce pain and improve mobility. Teriparatide is used to stimulate new bone formation. Companies in the Osteogenesis Imperfecta Drug market include Amgen, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more